Newsroom

Allison Institute’s third annual scientific symposium highlighted by panel discussion with five Nobel laureates

October 28, 2025

Sessions focused on the latest advances in cancer vaccines, immunotherapy and immunology research Symposium featured a panel discussion with five Nobel laureates, moderated by TIME Senior Health Correspondent Alice Park

The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center hosted its third annual scientific symposium, “The Multiverse of Mechanistic Processes Impacting Immunity,” on Oct. 24 at the TMC3 ...

Leading cancer research centers reinforce importance of safe and effective HPV vaccination to prevent cancer

BY Clayton Boldt

September 16, 2025

62 NCI-designated cancer centers, leading national organizations and the University of Puerto Rico Comprehensive Cancer Center jointly endorse...

MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies

BY Clayton Boldt

September 05, 2025

Agreement focuses on rimiducid, an agent used to activate certain safety switch technologies in cell therapies Phoenix receives a supply of...

Novel tool helps identify key targets to strengthen CAR NK cell therapies

August 21, 2025

Researchers developed the first genome-wide CRISPR screening tool for primary human natural killer (NK) cells Study revealed critical regulators of NK cell activity that can be targeted to improve chimeric antigen receptor (CAR) NK cell therapies Findings open new avenues for developing more effective CAR NK cell therapies for many cancers

HOUSTON, AUGUST 21, 2025 ― Natural killer (NK) cells became markedly better at killing cancer...

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

BY Julie Nagy

August 20, 2025

Study finds cancer cells break down protective nerve coverings, leading to nerve injury and chronic inflammation These nerve injuries drive...

MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments

BY Clayton Boldt

July 29, 2025

3D cell culture technology may allow researchers to rapidly test a variety of treatments directly on patient biopsies Teams will evaluate technology...